Peter W. P. T. Pisters
#157,963
Most Influential Person Now
Peter W. P. T. Pisters's AcademicInfluence.com Rankings
Peter W. P. T. Pistersphilosophy Degrees
Philosophy
#8991
World Rank
#12480
Historical Rank
Logic
#5997
World Rank
#7467
Historical Rank
Download Badge
Philosophy
Why Is Peter W. P. T. Pisters Influential?
(Suggest an Edit or Addition)Peter W. P. T. Pisters's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial (2009) (1246)
- Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. (1996) (1116)
- NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors. (2010) (1010)
- Effect of Laparoscopic-Assisted Resection vs Open Resection of Stage II or III Rectal Cancer on Pathologic Outcomes: The ACOSOG Z6051 Randomized Clinical Trial. (2015) (877)
- Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. (1996) (857)
- Borderline Resectable Pancreatic Cancer: Definitions, Management, and Role of Preoperative Therapy (2006) (762)
- Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. (2008) (730)
- Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head. (2008) (699)
- NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines. (2007) (623)
- Soft tissue sarcomas of adults: state of the translational science. (2003) (559)
- Pancreaticoduodenectomy with vascular resection: margin status and survival duration (2004) (545)
- Impact of Resection Status on Pattern of Failure and Survival After Pancreaticoduodenectomy for Pancreatic Adenocarcinoma (2007) (538)
- Prognostic factors for patients with localized soft‐tissue sarcoma treated with conservation surgery and radiation therapy (2003) (497)
- Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy. (1999) (465)
- Long-Term Survival After Multidisciplinary Management of Resected Pancreatic Adenocarcinoma (2009) (449)
- Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators (2012) (444)
- Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head. (2008) (444)
- Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression. (1997) (429)
- Primary treatment of cystosarcoma phyllodes of the breast (2000) (366)
- Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response. (2006) (341)
- Neoadjuvant Chemoradiotherapy for Adenocarcinoma of the Pancreas: Treatment Variables and Survival Duration (2001) (336)
- Alveolar soft part sarcoma (2001) (319)
- Risk Factors for Pancreatic Cancer: Case-Control Study (2007) (317)
- Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma. (2004) (315)
- Borderline Resectable Pancreatic Cancer: Need for Standardization and Methods for Optimal Clinical Trial Design (2013) (304)
- Effect of Preoperative Biliary Decompression on Pancreaticoduodenectomy-Associated Morbidity in 300 Consecutive Patients (2001) (302)
- A Prospective Randomized Trial of Total Parenteral Nutrition After Major Pancreatic Resection for Malignancy (1994) (272)
- Surgical Resection of Gastrointestinal Stromal Tumors After Treatment with Imatinib (2006) (268)
- Optimizing treatment of desmoid tumors. (2007) (267)
- Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration in patients with presumed pancreatic cancer (2003) (265)
- Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome. (2005) (262)
- Combined Modality Treatment of Resectable and Borderline Resectable Pancreas Cancer: Expert Consensus Statement (2009) (259)
- Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trial. (2014) (252)
- Long-Term Results of Two Prospective Trials of Preoperative External Beam Radiotherapy for Localized Intermediate- or High-Grade Retroperitoneal Soft Tissue Sarcoma (2006) (227)
- Disease-free Survival and Local Recurrence for Laparoscopic Resection Compared With Open Resection of Stage II to III Rectal Cancer: Follow-up Results of the ACOSOG Z6051 Randomized Controlled Trial (2019) (217)
- Prognostic factors and survival of patients with sarcomatoid renal cell carcinoma. (2002) (216)
- Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer? (2001) (213)
- Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer. (2006) (207)
- Preoperative paclitaxel and concurrent rapid-fractionation radiation for resectable pancreatic adenocarcinoma: toxicities, histologic response rates, and event-free outcome. (2002) (190)
- Surgical margins and reresection in the management of patients with soft tissue sarcoma using conservative surgery and radiation therapy (2003) (190)
- Cost and Utilization Impact of a Clinical Pathway for Patients Undergoing Pancreaticoduodenectomy (2000) (185)
- The learning curve in pancreatic surgery. (2007) (181)
- Treatment Sequencing for Resectable Pancreatic Cancer: Influence of Early Metastases and Surgical Complications on Multimodality Therapy Completion and Survival (2013) (174)
- Complications of combined modality treatment of primary lower extremity soft‐tissue sarcomas (2006) (171)
- Retroperitoneal sarcomas: Combined‐modality treatment approaches (2002) (163)
- CPT‐11 plus cisplatin in patients with advanced, untreated gastric or gastroesophageal junction carcinoma (2002) (163)
- The role of radiation therapy in the management of dermatofibrosarcoma protuberans. (1998) (162)
- Cohort analysis of patients with localized, high-risk, extremity soft tissue sarcoma treated at two cancer centers: chemotherapy-associated outcomes. (2004) (156)
- Adult prostate sarcoma: the M. D. Anderson Cancer Center Experience. (2001) (154)
- Adult rhabdomyosarcoma (2002) (154)
- Microscopically positive margins for primary gastrointestinal stromal tumors: analysis of risk factors and tumor recurrence. (2012) (149)
- Perineural and Intraneural Invasion in Posttherapy Pancreaticoduodenectomy Specimens Predicts Poor Prognosis in Patients With Pancreatic Ductal Adenocarcinoma (2012) (146)
- Preoperative vs. postoperative radiotherapy in the treatment of soft tissue sarcomas: a matter of presentation. (1998) (144)
- Evidence-based recommendations for local therapy for soft tissue sarcomas. (2007) (144)
- Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancer. (2014) (144)
- Retroperitoneal soft tissue sarcoma: an analysis of radiation and surgical treatment. (2007) (143)
- New Perspectives for Staging and Prognosis in Soft Tissue Sarcoma (2008) (142)
- Is there a role for surgery in patients with "unresectable" cKIT+ gastrointestinal stromal tumors treated with imatinib mesylate? (2003) (139)
- Patterns of recurrence in extremity liposarcoma (1999) (138)
- Phase I trial of preoperative concurrent doxorubicin and radiation therapy, surgical resection, and intraoperative electron-beam radiation therapy for patients with localized retroperitoneal sarcoma. (2003) (137)
- Intraductal Papillary Mucinous Neoplasms of the Pancreas: Effect of Invasion and Pancreatic Margin Status on Recurrence and Survival (2006) (135)
- A prospective randomized trial of adjuvant brachytherapy in the management of low-grade soft tissue sarcomas of the extremity and superficial trunk. (1994) (134)
- Serum CA 19-9 as a Marker of Resectability and Survival in Patients with Potentially Resectable Pancreatic Cancer Treated with Neoadjuvant Chemoradiation (2010) (132)
- Angiosarcoma of the breast (2005) (132)
- Preoperative vs. postoperative radiation therapy for soft tissue sarcoma: a retrospective comparative evaluation of disease outcome. (2003) (131)
- Rad51 overexpression contributes to chemoresistance in human soft tissue sarcoma cells: a role for p53/activator protein 2 transcriptional regulation (2007) (131)
- Major vascular resection as part of pancreaticoduodenectomy for cancer: Radiologic, intraoperative, and pathologic analysis (1999) (129)
- Long-term Results of Prospective Trial of Surgery Alone With Selective Use of Radiation for Patients With T1 Extremity and Trunk Soft Tissue Sarcomas (2007) (126)
- The learning curve in pancreatic surgery (DOI: 10.1016/j.surg.2006.09.013) (2007) (125)
- Spermatic cord sarcoma: outcome, patterns of failure and management. (2001) (124)
- Retroperitoneal sarcoma (2006) (123)
- Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Experience (2016) (122)
- Prognostic factors for disease-specific survival after first relapse of soft-tissue sarcoma: analysis of 402 patients with disease relapse after initial conservative surgery and radiotherapy. (2003) (120)
- Resection of some -- but not all -- clinically uninvolved adjacent viscera as part of surgery for retroperitoneal soft tissue sarcomas. (2009) (119)
- Delayed recovery after pancreaticoduodenectomy: a major factor impairing the delivery of adjuvant therapy? (2007) (118)
- Carcinoid tumors of the duodenum. (2005) (115)
- Postoperative nomogram for survival of patients with retroperitoneal sarcoma treated with curative intent. (2010) (112)
- Preoperative chemotherapy for stage IIIB extremity soft tissue sarcoma: long-term results from a single institution. (1997) (112)
- Radiographic response to neoadjuvant chemotherapy is a predictor of local control and survival in soft tissue sarcomas (2002) (112)
- Polymorphisms of cytochrome P4501A2 and N-acetyltransferase genes, smoking, and risk of pancreatic cancer. (2006) (111)
- Insulin secretion and action in patients with pancreatic cancer (1991) (111)
- Multifocality in Retroperitoneal Sarcoma: A Prognostic Factor Critical to Surgical Decision-Making (2009) (105)
- Does Neoadjuvant Treatment for Gastric Cancer Patients with Positive Peritoneal Cytology at Staging Laparoscopy Improve Survival? (2008) (104)
- Influence of obesity on cancer-related outcomes after pancreatectomy to treat pancreatic adenocarcinoma. (2009) (102)
- Radiographic Tumor–Vein Interface as a Predictor of Intraoperative, Pathologic, and Oncologic Outcomes in Resectable and Borderline Resectable Pancreatic Cancer (2014) (101)
- Hemangiopericytoma: A 20-year single-institution experience (1998) (100)
- Enhanced staging and all chemotherapy preoperatively in patients with potentially resectable gastric carcinoma. (1999) (100)
- Extraosseous osteosarcoma: response to treatment and long-term outcome. (2002) (99)
- Pathologic complete response to neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma is associated with a better prognosis. (2012) (98)
- Up-regulation of vascular endothelial growth factor in breast cancer cells by the heregulin-beta1-activated p38 signaling pathway enhances endothelial cell migration. (2001) (98)
- The Effect of Preoperative Radiotherapy and Reconstructive Surgery on Wound Complications after Resection of Extremity Soft-Tissue Sarcomas (2006) (96)
- Effect of Neoadjuvant Chemoradiation and Surgical Technique on Recurrence of Localized Pancreatic Cancer (2011) (96)
- Pancreaticoduodenectomy after placement of endobiliary metal stents (2005) (93)
- Feasibility of a randomized trial of extended lymphadenectomy for pancreatic cancer. (2005) (91)
- Effect of hyperinsulinemia on whole body and skeletal muscle leucine carbon kinetics in humans. (1992) (91)
- Multicenter phase II trial of adjuvant therapy for resected pancreatic cancer using cisplatin, 5-fluorouracil, and interferon-alfa-2b-based chemoradiation: ACOSOG Trial Z05031. (2011) (90)
- Neoadjuvant Therapy is Associated with a Reduced Lymph Node Ratio in Patients with Potentially Resectable Pancreatic Cancer (2015) (89)
- Angiogenesis-Promoting Gene Patterns in Alveolar Soft Part Sarcoma (2007) (88)
- Locoregional Disease Patterns in Well-Differentiated and Dedifferentiated Retroperitoneal Liposarcoma: Implications for the Extent of Resection? (2014) (87)
- Epithelioid sarcoma: results of conservative surgery and radiotherapy. (2001) (86)
- Long-term outcomes for synovial sarcoma treated with conservation surgery and radiotherapy. (2007) (84)
- Adjuvant imatinib mesylate in patients with primary high risk gastrointestinal stromal tumor (GIST) following complete resection: Safety results from the U.S. Intergroup Phase II trial ACOSOG Z9000 (2005) (84)
- Risk of venous thromboembolism outweighs post-hepatectomy bleeding complications: analysis of 5651 National Surgical Quality Improvement Program patients. (2012) (84)
- Venous resection in pancreatic cancer surgery. (2006) (81)
- Long-segment, supercharged, pedicled jejunal flap for total esophageal reconstruction. (2005) (80)
- Yield of clinical and radiographic surveillance in patients with resected pancreatic adenocarcinoma following multimodal therapy. (2012) (80)
- Impact of neoadjuvant chemotherapy on postoperative morbidity in soft tissue sarcomas. (2000) (80)
- Pleomorphic liposarcoma (2011) (79)
- Retroperitoneal sarcoma: A population-based analysis of epidemiology, surgery, and radiotherapy (2005) (79)
- Localized adenocarcinoma of the pancreas: the rationale for preoperative chemoradiation. (2002) (79)
- Anatomy of the Superior Mesenteric Vein With Special Reference to the Surgical Management of First-order Branch Involvement at Pancreaticoduodenectomy (2008) (78)
- Protein and amino acid metabolism in cancer cachexia: investigative techniques and therapeutic interventions. (1993) (78)
- Re-resection with brachytherapy for locally recurrent soft tissue sarcoma arising in a previously radiated field. (1999) (76)
- Staging and preoperative evaluation of upper gastrointestinal malignancies. (2004) (75)
- Post‐therapy pathologic stage and survival in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation (2012) (75)
- Phase I trial of preoperative doxorubicin-based concurrent chemoradiation and surgical resection for localized extremity and body wall soft tissue sarcomas. (2004) (74)
- Relation of tumor pathologic and molecular features to outcome after surgical resection of localized primary gastrointestinal stromal tumor (GIST): Results of the intergroup phase III trial ACOSOG Z9001. (2010) (74)
- Clinicopathologic behavior of gastric adenocarcinoma in Hispanic patients: analysis of a single institution's experience over 15 years. (2005) (74)
- Role of adjuvant chemoradiation therapy in adenocarcinomas of the ampulla of vater. (2008) (73)
- Standardization of Surgical and Pathologic Variables is Needed in Multicenter Trials of Adjuvant Therapy for Pancreatic Cancer: Results from the ACOSOG Z5031 Trial (2011) (71)
- Phase I study of concomitant gemcitabine and IMRT for patients with unresectable adenocarcinoma of the pancreatic head (2001) (70)
- Selective Reoperation for Locally Recurrent or Metastatic Pancreatic Ductal Adenocarcinoma Following Primary Pancreatic Resection (2012) (68)
- Establishing Prognosis in Retroperitoneal Sarcoma: A New Histology-Based Paradigm (2009) (68)
- 5,10-Methylenetetrahydrofolate Reductase Polymorphisms and the Risk of Pancreatic Cancer (2005) (67)
- Histologic tumor involvement of superior mesenteric vein/portal vein predicts poor prognosis in patients with stage II pancreatic adenocarcinoma treated with neoadjuvant chemoradiation (2012) (64)
- The effects of euglycemic hyperinsulinemia and amino acid infusion on regional and whole body glucose disposal in man. (1991) (64)
- Amino acid metabolism in human cancer cachexia. (1990) (63)
- Neoadjuvant therapy for resectable pancreatic cancer. (2004) (62)
- Complete Soft Tissue Sarcoma Resection is a Viable Treatment Option for Select Elderly Patients (2009) (62)
- Development of an Integrated Biospecimen Bank and Multidisciplinary Clinical Database For Pancreatic Cancer (2008) (61)
- Interval between surgery and radiotherapy: effect on local control of soft tissue sarcoma. (2004) (60)
- Management of locally recurrent soft-tissue sarcoma after prior surgery and radiation therapy. (2007) (60)
- Toxicity and Outcomes Associated with Surgical Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Patients with Sarcomatosis (2007) (59)
- Long-term outcome of patients with American Joint Committee on Cancer stage IIB extremity soft tissue sarcomas. (1999) (58)
- An improved Knott's concentration test for the detection of microfilariae. (2000) (56)
- Impact of Induction Chemotherapy and Preoperative Chemoradiotherapy on Operative Morbidity and Mortality in Patients with Locoregional Adenocarcinoma of the Stomach or Gastroesophageal Junction (2007) (56)
- Retroperitoneal dissection in patients with borderline resectable pancreatic cancer: operative principles and techniques. (2012) (55)
- Tumor volume as a prognostic factor for sarcomatosis (2002) (55)
- The effect of systemic hyperinsulinemia with concomitant amino acid infusion on skeletal muscle protein turnover in the human forearm. (1994) (55)
- Frequency and Intensity of Postoperative Surveillance After Curative Treatment of Pancreatic Cancer: A Cost-Effectiveness Analysis (2013) (55)
- Utility of chest computed tomography for staging in patients with T1 extremity soft tissue sarcomas (2001) (52)
- Total pelvic exenteration: effective palliation of perineal pain in patients with locally recurrent prostate cancer. (2003) (52)
- Irinotecan/cisplatin in advanced, treated gastric or gastroesophageal junction carcinoma. (2002) (51)
- Fear of Cancer Recurrence after Curative Pancreatectomy: A Cross-sectional Study in Survivors of Pancreatic and Periampullary Tumors (2012) (51)
- Clinical calculator of conditional survival estimates for resected and unresected survivors of pancreatic cancer. (2012) (49)
- Staging and prognostic factors in soft tissue sarcoma. (1999) (49)
- Superior Mesenteric Artery Margin of Posttherapy Pancreaticoduodenectomy and Prognosis in Patients With Pancreatic Ductal Adenocarcinoma (2015) (49)
- Neoadjuvant chemotherapy–specific and overall treatment outcomes in patients with cutaneous angiosarcoma of the face with periorbital involvement (2008) (46)
- Cost-effectiveness of pulmonary resection and systemic chemotherapy in the management of metastatic soft tissue sarcoma: a combined analysis from the University of Texas M. D. Anderson and Memorial Sloan-Kettering Cancer Centers. (2004) (45)
- Irinotecan and cisplatin in advanced gastric or gastroesophageal junction carcinoma. (2000) (45)
- Tumor Invasion of Muscular Vessels Predicts Poor Prognosis in Patients With Pancreatic Ductal Adenocarcinoma Who Have Received Neoadjuvant Therapy and Pancreaticoduodenectomy (2012) (45)
- Selective reoperation for locally recurrent or metastatic pancreatic ductal adenocarcinoma following primary pancreatic resection. (2012) (44)
- The effect of graded doses of insulin on peripheral glucose uptake and lactate release in cancer cachexia. (1991) (43)
- The argument for pre-operative chemoradiation for localized, radiographically resectable pancreatic cancer. (2006) (42)
- Insulin action on glucose and branched-chain amino acid metabolism in cancer cachexia: differential effects of insulin. (1992) (41)
- Effect of systemic hyperinsulinemia in cancer patients. (1992) (41)
- Metastasectomy for limited metastases from soft tissue sarcoma (2002) (41)
- Surgical pathology stage by American Joint Commission on Cancer criteria predicts patient survival after preoperative chemoradiation for localized gastric carcinoma (2006) (41)
- Outcome of gastric cancer patients after successful gastrectomy (2006) (41)
- The follow-up of adult soft-tissue sarcomas. (2003) (40)
- Administration of optimal biological dose and schedule of interferon alpha combined with gemcitabine induces apoptosis in tumor-associated endothelial cells and reduces growth of human pancreatic carcinoma implanted orthotopically in nude mice. (2003) (40)
- Morbidity and Mortality after Pancreaticoduodenectomy in Patients with Borderline Resectable Type C Clinical Classification (2013) (39)
- Periosteal margin in soft‐tissue sarcoma (2007) (38)
- Lymphadenectomy for isolated lymph node metastasis from extremity soft‐tissue sarcomas (2008) (38)
- Borderline Resectable Pancreatic Cancer: What Have We Learned and Where Do We Go From Here? (2011) (37)
- Modified Makuuchi incision for foregut procedures. (2010) (37)
- Cost‐effectiveness of staging computed tomography of the chest in patients with T2 soft tissue sarcomas (2002) (35)
- Analysis of Prognostic Factors Impacting Oncologic Outcomes After Neoadjuvant Tyrosine Kinase Inhibitor Therapy for Gastrointestinal Stromal Tumors (2014) (35)
- Concurrent ifosfamide‐based chemotherapy and irradiation (2001) (35)
- Preoperative chemoradiation treatment strategies for localized sarcoma (2007) (35)
- Current Approaches and Future Strategies for Pancreatic Carcinoma (2000) (34)
- Retroperitoneal sarcomas: combined modality treatment approaches. (2002) (33)
- A USA registry of gastrointestinal stromal tumor patients: changes in practice over time and differences between community and academic practices. (2011) (33)
- Combined modality treatment of extremity soft tissue sarcomas (1998) (33)
- The on-going debate about perioperative biliary drainage in jaundiced patients undergoing pancreaticoduodenectomy. (2002) (32)
- Future chemoradiation strategies in pancreatic cancer. (2007) (32)
- Strength of the Evidence: Adjuvant Therapy for Resected Pancreatic Cancer (2008) (32)
- ACCO: ASCO core curriculum outline. (2005) (32)
- Current status of adjuvant therapy for pancreatic cancer. (2010) (31)
- Predicting the risks of venous thromboembolism versus post-pancreatectomy haemorrhage: analysis of 13,771 NSQIP patients. (2014) (31)
- Locally recurrent soft tissue sarcoma of the extremities. (1998) (30)
- The effect of insulin on glucose and protein metabolism in the forearm of cancer patients. (1992) (30)
- Superior Mesenteric Artery Pseudoaneurysm Following Pancreaticoduodenectomy: Management by Endovascular Stent-Graft Placement and Transluminal Thrombin Injection (2007) (30)
- Pilot Study of Concurrent 5-Fluorouracil/Paclitaxel Plus Radiotherapy in Patients With Carcinoma of the Esophagus and Gastroesophageal Junction (2001) (29)
- Staging and prognostic factor evaluation in soft tissue sarcoma. (2003) (28)
- Combined-modality treatment of localized soft tissue sarcomas of the extremities. (2003) (28)
- Attempted Salvage Resection for Recurrent Gastric or Gastroesophageal Cancer (2008) (28)
- Survival and Quality of Life of Patients with Resected Pancreatic Adenocarcinoma Treated with Adjuvant Interferon-Based Chemoradiation: A Phase II Trial (2011) (27)
- Clinical stage after preoperative chemoradiation is a better predictor of patient outcome than the baseline stage for localized gastric cancer (2007) (26)
- Combined-modality treatment for operable pancreatic adenocarcinoma. (2005) (26)
- Gastric Adenocarcinoma in Young Patients: a Population-Based Appraisal (2007) (26)
- Infrequent mutation of the p16/MTS1 gene and overexpression of cyclin-dependent kinase 4 in human primary soft-tissue sarcoma. (1998) (26)
- Overexpression of Protein Phosphatase 4 Correlates with Poor Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma (2012) (25)
- ESPAC-1 trial of adjuvant therapy for resectable adenocarcinoma of the pancreas. (2002) (24)
- Preoperative chemotherapy and split-course radiation therapy for patients with localized soft tissue sarcomas: home run, base hit, or strike out? (2006) (24)
- Preoperative chemoradiation treatment strategies for localized sarcoma. (2002) (23)
- Preoperative therapy for soft tissue sarcoma. (2004) (22)
- ACOSOG Z05031: Report on a multicenter, phase II trial for adjuvant therapy of resected pancreatic cancer using cisplatin, 5- FU, and alpha-interferon (2008) (22)
- Irinotecan plus cisplatin in advanced gastric or gastroesophageal junction carcinoma. (2001) (22)
- Combined-modality therapy for gastric cancer. (2003) (21)
- Incidence, natural history, and patterns of locoregional recurrence in gastric cancer patients treated with preoperative chemoradiotherapy. (2008) (21)
- Clinical outcomes of molecularly confirmed clear cell sarcoma from a single institution and in comparison with data from the Surveillance, Epidemiology, and End Results registry (2009) (21)
- Loss of phosphatase and tensin homolog expression is associated with recurrence and poor prognosis in patients with pancreatic ductal adenocarcinoma. (2013) (20)
- Molecular prognosticators of complex karyotype soft tissue sarcoma outcome: a tissue microarray-based study. (2010) (19)
- Letter to the editor [1] (multiple letters) (2002) (19)
- Comment and perspective on Sewnath and colleagues' recent meta-analysis of the efficacy of preoperative biliary drainage for tumors causing obstructive jaundice. (2003) (18)
- Gastroesophageal junction adenocarcinoma (2000) (18)
- Adenocarcinoma of the pancreas: recent controversies, current management, and future therapies (1996) (18)
- Phase I study of irinotecan and concurrent radiation therapy for upper GI tumors. (2000) (17)
- JNCCN NCCN Task Force Report : Optimal Management of Patients with Gastrointestinal Stromal Tumor ( GIST ) — Update of the NCCN Clinical Practice Guidelines (2007) (17)
- A prospective evaluation of isolated limb perfusion with doxorubicin in patients with unresectable extremity sarcomas (2004) (17)
- Perioperative Gemcitabine + Erlotinib Plus Pancreaticoduodenectomy for Resectable Pancreatic Adenocarcinoma: ACOSOG Z5041 (Alliance) Phase II Trial (2019) (16)
- Prevalence of filarial antigenaemia in Papua Nnew Guinea: results of surveys by the School of Public Health and Tropical Medicine, James Cook University, Townsville, Australia. (2000) (15)
- Phase 1 adaptive dose‐finding study of neoadjuvant gemcitabine combined with radiation therapy for patients with high‐risk extremity and trunk soft tissue sarcoma (2015) (15)
- The learning curve in pancreatic surgery. (2007) (15)
- Solid pseudopapillary neoplasm of the pancreas with prominent atypical multinucleated giant tumour cells (2013) (14)
- Erratum: Effect of hyperinsulinemia on whole body and skeletal muscle leucine carbon kinetics in humans (American Journal of Physiology - Endocrinology and Metabolism (June 1992) (E911-E918)) (1993) (12)
- Novel applications of endo GIA linear staplers during pancreaticoduodenectomy and total pancreatectomy. (2003) (12)
- Gastrointestinal stromal tumors: Rationale for surgical adjuvant trials with imatinib (2002) (12)
- Fear of cancer recurrence and quality of life among survivors of pancreatic and periampullary neoplasms. (2012) (11)
- Retroperitoneal Sarcomas—An SOS to Colleagues in Europe (2007) (11)
- Improving Goal Concordant Care Among 10 Leading Academic U.S. Cancer Hospitals: A Collaboration of the Alliance of Dedicated Cancer Centers (2021) (10)
- Estimation of the Causal Effects on Survival of Two‐Stage Nonrandomized Treatment Sequences for Recurrent Diseases (2006) (10)
- Target Description for Radiotherapy of Soft Tissue Sarcoma (2004) (10)
- Preoperative gemcitabine (gem) and bevacizumab (bev)-based chemoradiation for resectable pancreatic adenocarcinoma (2008) (10)
- A phase II trial of preoperative chemotherapy and chemoradiotherapy for potentially resectable adenocarcinoma of the stomach (RTOG 99–04) (2005) (9)
- Metastatic patterns of extremity liposarcoma and their outcome (2002) (9)
- A Bayesian multivariate joint frailty model for disease recurrences and survival (2016) (8)
- Diagnosis and management of soft tissue sarcomas. (2008) (8)
- Treatment of localized soft-tissue sarcoma: lessons learned. (2007) (8)
- Regional Lymph Node Dissection for Pancreatic Adenocarcinoma (2002) (8)
- Operative trials: the opportunity beckons-an update on the American College of Surgeons Oncology Group. (2006) (7)
- Supporting hospital renewal through strategic environmental sustainability programs (2017) (7)
- Subaquatic laparoscopy for staging of intraabdominal malignancy. (2003) (6)
- Sarcomas of Nonosseous Tissues (2000) (6)
- Treatment related toxicities with rapid-fractionation external beam radiation therapy and concomitant gemcitabine for locally advanced nonmetastic adenocarcinoma of the pancreas (1998) (5)
- Development of anti-filarial antibodies in a group of expatriate mine-site workers with varying exposure to the disease. (2000) (5)
- Protein and Amino Acid Metabolism in Cancer Cachexia (1996) (5)
- Multicystic dedifferentiated retroperitoneal liposarcoma: tumour cyst fluid analysis and implications for management (2015) (5)
- Regionalization Does Not Equal Integration. (2016) (5)
- Preoperative Multimodality Treatment of Localized Soft Tissue Sarcoma: Addition Through Subtraction? (2005) (4)
- Cisplatin, fluorouracil, interferon-alpha, and radiation as adjuvant therapy for resected pancreatic cancer: is there a future for this regimen and/or should we change our approach to research and treatment of patients with pancreatic cancer? (2008) (4)
- 200 Treatment Sequencing for Resectable Pancreatic Cancer: Influence of Early Metastases and Surgical Complications on Multimodality Therapy Completion Rates and Survival (2013) (4)
- Preoperative (Neoadjuvant) Therapy for Resectable Adenocarcinoma of the Pancreas (2002) (3)
- Multimodality therapy for adenocarcinoma of the pancreas: The M.D. Anderson experience (1997) (3)
- Comparative Age-Based Prospective Multi-Institutional Observations of 12,367 Patients Enrolled to the American College of Surgeons Oncology Group (ACOSOG) Z901101 Trials (Alliance) (2019) (3)
- Standard Forms of Pancreatic Resection (1998) (3)
- The role of surgery in the multidisciplinary management of patients with localized gastrointestinal stromal tumors (2012) (3)
- Phase I trial using toxicity severity weights for dose finding of gemcitabine combined with radiation therapy and subsequent surgery for patients with extremity and trunk soft tissue sarcomas (2004) (3)
- Background and H2O2-induced micronuclei in peripheral blood lymphocytes as a risk factor for pancreatic cancer (2004) (3)
- Impact of an Interdisciplinary Goals-of-Care Program Among Medical Inpatients at a Comprehensive Cancer Center During the COVID-19 Pandemic: A Propensity Score Analysis (2022) (3)
- New developments in soft tissue sarcoma. (1997) (3)
- Surgical Oncology Trials and Surgeons in the Real World! (2010) (3)
- Defining Core Information for the Training and Continuing Education of Surgical Oncologists (2001) (2)
- The length of time between surgery and post-operative radiotherapy and local control for soft tissue sarcoma (2003) (2)
- Quality assessment across a national cancer network. (2013) (2)
- Phase I trial using toxicity severity weights for dose finding of gemcitabine combined with radiation therapy and subsequent surgery for patients with extremity and trunk soft tissue sarcomas. (2004) (2)
- COMMENTARY: Preoperative Chemoradiation Therapy for Pancreatic Cancer (2001) (2)
- Electronic synoptic operative reporting for pancreatic resection. (2011) (2)
- Presumed malignant biliary obstruction despite a normal CT: Data to support pancreatico-duodentectomy (PD) (1998) (2)
- Pancreatic ductal adenocarcinoma: neoadjuvant therapies and pathology (2014) (2)
- Improving breast cancer quality of care with the use of patient navigators (2011) (2)
- Comparison of pathologic response among three pre-operative chemoradiation regimens for resectable, locally advanced stomach cancer (2000) (2)
- Radiation Therapy Oncology Group. Research Plan 2002-2006. Surgical Oncology Committee. (2001) (2)
- Resectable recurrent extremity sarcomas: is there a role for re-irradiation? (1999) (2)
- Enteral Nutrition in Cancer (1996) (1)
- Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration of cystic lesions of the pancreas (2003) (1)
- Resection of uninvolved adjacent organs can be part of surgery for retroperitoneal soft tissue sarcoma (2009) (1)
- Analysis of an observational registry of gastrointestinal stromal tumor (GIST) patients (pts) in the United States: reGISTry. (2008) (1)
- Adenocarcinoma of the pancreas (1996) (1)
- Treatment of Metastatic Disease (2003) (1)
- 153: Proximal versus total gastrectomy for proximal gastric cancer: A population-based appraisal (2007) (1)
- Misconceptions with staging of soft tissue sarcoma. (2000) (1)
- Total parenteral nutrition in cancer. (1981) (1)
- Adjuvant imatinib therapy of 208 gastrointestinal stromal tumor (GIST) patients: Dose, duration, and risk assessment. (2010) (1)
- Impact of Cancer Care Regionalization on Patient Volume (2022) (1)
- Novel Chemoradiation in Localized Pancreatic Cancer: Clinical Studies (2006) (1)
- Impact of Induction Chemotherapy and Preoperative Chemoradiotherapy on Operative Morbidity and Mortality in Patients with Locoregional Adenocarcinoma of the Stomach or Gastroesophageal Junction (2006) (1)
- New Models for the New Healthcare Healthcare Papers Regionalization : What Have We Learned ? (2016) (1)
- Aggressive combined modality therapy for recurrent colorectal cancer involving the duodenum and pancreas: a report of 5 cases. (2008) (0)
- reGISTry: An observational registry of gastrointestinal stromal tumor (GIST) patients (pts) in the USA. (2016) (0)
- Figure 122.13, [Schema for approaching the patient...]. (2000) (0)
- The effect of ethnicity on presentation, pattern of metastasis, and survival in gastric adenocarcinoma at a single center. (2004) (0)
- Analysis of a United States observational registry of gastrointestinal stromal tumor (GIST) patients (pts): reGISTry (2007) (0)
- Computer-Based Literature Searches (1998) (0)
- [Frontiers in Bioscience 3, e194-204, November 1, 1998] 194 NEOADJUVANT CHEMORADIATION FOR ADENOCARCINOMA OF THE PANCREAS (1998) (0)
- Selected Reports Evaluating Surgical Treatment of Primary Retroperitoneal Soft Tissue Sarcomas (2005) (0)
- Multifocality and overall survival in retroperitoneal sarcoma (2008) (0)
- 131 Pharmacodynamic analysis of apoptosis and anti-vascular activity in GIST patients treated with Imatinib (2004) (0)
- Improved outcomes in patients with lymph node-only stage IV disease in clear cell sarcoma: Results from a large single-institution experience and SEER database analysis (2008) (0)
- 980 Preliminary results of a phase I study of rhumab VEGF (bevacizumab) with concurrent radiotherapy (XRT) and capecitabine (CAP) in locally advanced pancreatic cancer (2003) (0)
- Enhanced S taging a nd A ll C hemotherapy P reoperatively i n Patients w ith P otentially R esectable G astric C arcinoma (1999) (0)
- Extraosseous O steosarcoma: R esponse t o T reatment a nd Long-Term O utcome (2002) (0)
- Evolution of multimodality management of gastrointestinal stromal tumors of the stomach. (2011) (0)
- Adult rhabdomyosarcoma: Outcome and prognostic factors (2001) (0)
- Pancreas and Biliary Tree (2015) (0)
- Seventh Americas Hepatopancreatobiliary Congress ANNUAL SCIENTIFIC SESSION & POST GRADUATE PROGRAM April 19-22, 2007 Bally's Hotel Las Vegas, Nevada. (2007) (0)
- Staging and Prognostic Factors (2003) (0)
- 9401 ORAL Chemotherapy Treatment Patterns in Patients With Metastatic Soft Tissue Sarcoma – the Sarcoma Treatment and Burden of Illness in North America and Europe (SABINE) Study (2011) (0)
- Surgical Innovators Past and Present—Reply (2010) (0)
- Stromal Tumors of the Small Bowel (2009) (0)
- A flexible‐hazards cure model with application to patients with soft tissue sarcoma (2022) (0)
- 778 Morbidity and Mortality After Pancreaticoduodenectomy in Patients With Borderline Resectable Type C Clinical Classification (2013) (0)
- Additional Issues in Soft-Tissue Sarcoma Management (2003) (0)
- MD Anderson’s 10-year experience with regional surgical oncology in the Houston area locations (2021) (0)
- Staging and Therapeutic Approaches for Patients with Localized, Potentially Curable Pancreatic Adenocarcinoma (2005) (0)
- Symptom burden in gastrointestinal stromal tumors (GIST). (2011) (0)
- Pancreaticoduodenectomy for suspected cancer: Can patients with benign histopathology be identified prior to surgery? (2003) (0)
- Abstracts reprinted from Journal of Clinical Oncology (2007) (0)
- 7009 Endoscopic ultrasound guided fine needle aspiration of solid pancreatic lesions: one year md anderson cancer center experience. (2000) (0)
- Pancreatic cancer : with 109 illustrations (2002) (0)
- Treatment of Locally Advanced Disease (2003) (0)
- Use of operability classifications to predict outcome of patients with anatomically resectable pancreatic adenocarcinoma treated with neoadjuvant therapy. (2012) (0)
- Phase I study of neoadjuvant gemcitabine combined with radiation therapy for patients with high-risk extremity and trunk soft tissue sarcomas. (2014) (0)
- ASO Visual Abstract: Impact of Cancer Care Regionalization on Patient Volume (2023) (0)
- Nonstandard dosing in gastrointestinal stromal tumors: A registry observation. (2010) (0)
- Surgical oncology committee (2001) (0)
- Abstract 5527: Overexpression of protein phosphatase 4 is associated with poor prognosis in patients with pancreatic ductal adenocarcinoma (2012) (0)
- Signal Transduction Inhibition for Gastrointestinal Stromal Tumors and Dermatofibrosarcoma Protuberans (2003) (0)
- Treatment of Borderline Resectable Pancreatic Cancer with Neoadjuvant Treatment (2013) (0)
- Treatment of Localized Primary Disease of the Extremities (2003) (0)
- Incidence and Impact of a Close Superior Mesenteric Artery Margin Following Pancreaticoduodenectomy for Adenocarcinoma (2011) (0)
- 214 : The Role of Re-irradiation in the Management of Locally Recurrent Soft Tissue Sarcoma After Prior Surgery and Radiation Therapy (2006) (0)
- Effect of Systemic Hyperinsulinemia in Cancer Patients1 (2006) (0)
- Diagnosis and initial evaluation of patients with gastrointestinal stromal tumor (GIST): An observational study of 1,226 patients. (2012) (0)
- Management of Local Recurrence (2003) (0)
- Resection of the Superior Mesenteric-Portal Vein Confluence During Pancreaticoduodenectomy (1997) (0)
- A phase II study of pre- and post-operative gemcitabine and erlotinib plus pancreaticoduodenectomy (PD) for patients with resectable pancreatic ductal adenocarcinoma (PDAC): ACOSOG Z5041 trial (Alliance). (2018) (0)
- 861 A Standardized Radiographic Assessment of the Tumor-Vein Interface Predicts the Need for Venous Resection and the Presence of Histologic Venous Invasion in Borderline Resectable Pancreatic Cancer (2013) (0)
- Clinical Presentation, Classification, and Diagnosis (2003) (0)
- Contemporay assessment of extrahepatic bile duct strictures (2003) (0)
- Commentary (2001) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Peter W. P. T. Pisters?
Peter W. P. T. Pisters is affiliated with the following schools:
